Colin Rom leads policy for Andreessen Horowitz’s Bio + Health practice. Previously, he was managing director of science and innovation policy at Mayo Clinic, leading federal engagement on AI, biotechnology, and care delivery. At the FDA, he became senior advisor to the commissioner, served as liaison to the White House Coronavirus Task Force, and participated in Operation Warp Speed. He also advised the director of health programs at the White House Office of Management and Budget and worked on health policy for Senator Richard Burr and the Senate HELP Committee.
Colin Rom leads policy for Andreessen Horowitz’s Bio + Health practice. Previously, he was managing director of science and innovation policy at Mayo Clinic, leading federal engagement on AI, biotechnology, and care delivery. At the FDA, he became senior advisor to the commissioner, served as liaison to the White House Coronavirus Task Force, and participated in Operation Warp Speed. He also advised the director of health programs at the White House Office of Management and Budget and worked on health policy for Senator Richard Burr and the Senate HELP Committee.
Career
Colin Rom studied at The Johns Hopkins University.
Head of Policy, Bio + Health at Andreessen Horowitz (a16z) until Present